DENTSPLY SIRONA INC (XRAY) Stock News
NASDAQ:XRAY - Nasdaq - US24906P1093 - Common Stock - Currency: USD
XRAY Latest News, Press Relases and Analysis
Why Dividend King Nordson's Stock Popped This Week
The industrial conglomerate notched convincing top- and bottom-line beats in its latest quarter. Dividend King Nordson (NASDAQ: NDSN) was looking impressively regal on the stock market over the past few days, thanks largely to quarterly results that satisfied investors. With that tailwind at its back, according to data compiled by S&P Global Market Intelligence, the diversified industrial conglomerate's shares finished the week almost 10% higher in price.
3 Reasons to Buy Carnival Stock Like There's No Tomorrow
Carnival reported record revenue, operating income, and customer deposits in Q1, highlighting its strong momentum. There were others, like Carnival (NYSE: CCL), that struggled because operations had to be temporarily shut down for safety concerns. When Carnival was forced to dock its ships, unsurprisingly, there was no way to service any demand.
Earnings Estimates Moving Higher for Dentsply (XRAY): Time to Buy?
Dentsply (XRAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
XRAY vs. COO: Which Stock Should Value Investors Buy Now?
XRAY vs. COO: Which Stock Is the Better Value Option?
Mentions: COO
Are Investors Undervaluing Dentsply Sirona (XRAY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Dentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the
XRAY or COO: Which Is the Better Value Stock Right Now?
XRAY vs. COO: Which Stock Is the Better Value Option?
Mentions: COO
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Top 4 Value Stocks With Impressive PEG Ratios to Buy Now
Here are the four discounted PEG-based value stocks that qualify our screening criteria- URBN, XRAY, LTM and EXEL.
Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer
CHARLOTTE, N.C., May 29, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the
Cooper Companies Q2 Earnings Likely to Reflect Seasonal Trends
COO's fiscal second-quarter results are expected to follow seasonal trends, with a lighter start compared to the previous two reported quarters.
Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference
CHARLOTTE, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the
Is Dentsply Sirona (XRAY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Dentsply International (XRAY) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Dentsply (XRAY) Reliance on International Sales: What Investors Need to Know
Evaluate Dentsply's (XRAY) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Dentsply (XRAY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Dentsply International (XRAY) Surpasses Q1 Earnings and Revenue Estimates
Dentsply (XRAY) delivered earnings and revenue surprises of 48.28% and 3.22%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: COO
Dentsply Sirona Reports First Quarter 2025 Results
Net sales of $879 million decreased (7.7%), organic sales decreased (4.4%) including a (4.0%) Byte sales impactGAAP gross margin of 53.0%, GAAP net income...
Stay Ahead of the Game With Dentsply (XRAY) Q1 Earnings: Wall Street's Insights on Key Metrics
Get a deeper insight into the potential performance of Dentsply (XRAY) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?
XRAY is likely to have faced a tough first quarter with Byte's revenue loss, weak U.S. equipment demands and implant pressures.
Pro-Dex, Inc. (PDEX) Q3 Earnings Surpass Estimates
ProDex (PDEX) delivered earnings and revenue surprises of 108.51% and 1.62%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PDEX
Earnings Preview: Dentsply International (XRAY) Q1 Earnings Expected to Decline
Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Align Technology (ALGN) Q1 Earnings and Revenues Top Estimates
Align Technology (ALGN) delivered earnings and revenue surprises of 7.58% and 0.67%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: ALGN